AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2024
Sep 9, 2024
30016_dirs_2024-09-09_256901ee-6278-45a0-a732-7b499bf66904.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-09-06
Reporting Person: AYERS JONATHAN W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-06 | Common Stock | G | 230000 | — | Disposed | 35651 | Direct |
| 2024-09-06 | Common Stock | G | 302179 | — | Disposed | 0 | Indirect |
| 2024-09-06 | Common Stock | G | 419574 | — | Acquired | 419574 | Indirect |
| 2024-09-06 | Common Stock | G | 112605 | — | Acquired | 122605 | Indirect |
Footnotes
F1: The reporting person is the grantor and trustee of the Jonathan W. Ayers 2022 GRAT ('2022 GRAT'). The 2022 GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2: The reporting person is the grantor and trustee of the Jonathan W. Ayers 2024 GRAT ('2024 GRAT'). The 2024 GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13